Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in IVF/ICSI: a double blind, cross-over, pharmacokinetic study

S. Mackens, M. D. Brucker, K. Illingworth, H. Tournaye, C. Blockeel

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
Pages (from-to)418-419
JournalHuman Reproduction
Volume36
Publication statusPublished - Jul 2021

Cite this